Xbrane Biopharma to participate at Vator Securities Global Healthcare days

Corporate Information

English

News

Other Corporate Information

Xbrane Biopharma AB (publ) ("Xbrane" or "the Company”) represented by Martin Åmark, CEO, will today participate at Vator Securities Global Healthcare days in Vienna.

Xbrane also presents updated information regarding upcoming investor conferences and presentations:

Presentation of interim report, January – September 2019 (teleconference)
November 15th, 2019, at 10:00 CET

LSX Inv€$tival Showcase 2019, London
November 19th, 2019, at 13:30 GMT (14:30 CET)

Jefferies 2019 Global Healthcare Conference, London
November 20th –21st, 2019

Vator Securities Unicorn Summit, Stockholm
November 27th, 2019, at 13:55 CET

Vator Securities Global Healthcare Days, Tel Aviv
December 4th, 2019

Some dates above are slightly changed from previous version of the financial calendar.

About Us

Xbrane is a commercial phase Swedish biopharmaceutical company that develop and produces biosimilars. Xbrane has a patented protein production platform for development of biosimilars and world leading expertise in biosimilars. Xbrane’s headquarter is located in Solna outside of Stockholm and the company’s in-house research and development facilities are in Sweden and Italy. Xbrane is listed at Nasdaq Stockholm since September 2019 with the ticker XBRANE. For more information please visit www.xbrane.com.